LAKE WORTH, FL–(Marketwired – October 12, 2015) – TOCCA Life Holdings, Inc. (OTC PINK:TLIF) announced today that it is filing an application for FDA approval for the first of its products, “TOCCA Screen.” TOCCA Screen is expected to be the most comprehensive home drug test kit currently available.
LAKE WORTH, FL–(Marketwired – October 12, 2015) – TOCCA Life Holdings, Inc. (OTC PINK: TLIF) announced today that it is filing an application for FDA approval for the first of its products, “TOCCA Screen.” TOCCA Screen is expected to be the most comprehensive home drug test kit currently available.
With 1 out of 4 families in America affected by the disease of addiction, TOCCA’s bio technology focus on clinical laboratory toxicology and home based sobriety products used for early detection, is a key component of in its objective of creating accountability in the home and in the workplace.
Estimates of the total overall costs of substance abuse in the United States, including productivity and health-and crime-related costs, exceed $600 billion annually. This includes approximately $193 billion for illicit drugs, $193 billion for tobacco, and $235 billion for alcohol. Fortunately, treatment is available to help people counter addiction’s powerful disruptive effects. Early detection, as with any disease, is a critical component in treating the disease of addiction, along with treatment itself and appropriate after care. Clinical toxicology and in home drug testing addresses two of the critical steps in arresting the disease of addiction. First they allow for early detection and second they form part of an effective after care program, keeping the patients and those around them safe.
CEO, Tyler Cornell, stated, “Years before I entered the industry or recognized the statement that there was a drug epidemic in America was true, I was trying to humble down while keeping busy. Wal-Mart offered me a part time job if I tested ‘clean’ after taking their drug test. I was mortified thinking it was more of an accusation than a test. After thousands of life stories from clients, I applaud Wal-Mart’s policy and am ashamed of my own reaction because basic testing isn’t just for the employer’s benefit. It is early detection and accountability that saves lives. We want to help take the stigma out of drug testing and strive to teach the benefits of accountability for people willing to learn, before their futures are defined by jails, institutions and early deaths. When I commonly refer to our being a sober living company, I’m not just talking about a core clientele in a specific locale that we work, I’m talking about helping people help themselves, their families and workplaces. With 25% of America directly affected, TOCCA isn’t a real estate play because the disease is already in existing homes. We will be there for people at their homes or ours, on every level this first FDA product application for our first product, ‘TOCCA Screen,’ is just the start to our plans to help families across the country. I wanted to do this after witnessing the results of inaction and the problem of the stigma attached”
About TOCCA Life Holdings, Inc. (OTC PINK: TLIF):
Located in Lake Worth, Lantana and Boynton Beach, Florida, the first publicly traded sober living company focused on biotech industry solutions to create accountability through technology and early detection, TOCCA Life, offers clients more than the typical halfway house, recovery residence, sober or transitional living experience by opening up doors of interest that may spark a new passion for life while practicing the 12 Step Program in its safe, structured sober living environment. Extra precautions are being taken for the clients and the community with clinical toxicology testing, to monitor prescription drug use and make clients accountable for illicit drug use, as clients transform themselves back into productive members of society.
The statements made herein contain forward-looking statements that are based on management’s current expectations and assumptions and are subject to risks and uncertainties. If such risks or uncertainties materialize or such assumptions prove incorrect, our business, operating results, financial condition and stock price could be materially negatively affected. In some cases, forward-looking statements can be identified by terminology including “goal,” “believes” “objective,” “can,” “may,” “will,” or the negative of these terms or other comparable terminology. We operate in a rapidly-changing environment and new risks emerge from time to time. As a result, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements the Company may make.
Embedded Video Available: https://www.youtube.com/
TOCCA Life Holdings Inc. (TLIF)